Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapaquistat Acetate 50 mg vs Placebo in Hypercholesterolemia
NCT00532558Phase 3Terminated
- Sponsor
- Takeda
- Start
- Oct 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of lapaquistat in hypercholesterolemia, sponsored by Takeda. Started Oct 2007; status: terminated.
02
Drugs
lapaquistat
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00532558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532558.